RUNCORN, England--(BUSINESS WIRE)--Orbia Advance Corporation S.A.B. de C.V.’s (BMV: ORBIA*) Fluor & Energy Materials business today announces its readiness to advance construction of a larger scale medical propellant purification plant, marking a critical milestone in the metered-dose inhaler (MDI) industry's transition to low-global-warming-potential (GWP) inhalers. Once operational, the plant will significantly expand production capacity for Zephex® 152a (HFA 152a), a next-generation, env...
Read the full news release here
